Hygrometric Performances of Different High-Flow Nasal Cannula Devices: Bench Evaluation and Clinical Tolerance.

Respir Care

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Canada. Mr Delorme is affiliated with the Université Paris-Saclay, UVSQ, ERPHAN,Versailles, France.

Published: November 2021


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: High-flow nasal cannula (HFNC) is increasingly used for the management of respiratory failure. Settings include [Formula: see text], total gas flow, and temperature target. Resulting absolute humidity (AH) at the nasal cannula may affect clinical tolerance, and optimal settings with respect to hygrometry remain poorly documented.

Methods: A bench study was designed to assess AH delivered by 4 HFNC devices (Optiflow, Airvo 2, Precision Flow, and Hydrate) according to flow, ambient temperature, and other available settings. Clinical tolerance of different levels of hygrometry (20, 30, and 40 mg HO/L) was evaluated in 15 healthy volunteers.

Results: With [Formula: see text] set at 1.0, normal ambient temperature, and settings made accordingly to the manufacturers' recommendations, mean ± SD AH was 42.2 ± 3.1, 39.5 ± 1.8, 35.7 ± 2.0, and 32.9 ± 2.7 mg HO/L for the Airvo 2, Optiflow, Hydrate, and Precision Flow, respectively, ( < .001). AH dropped from -3.5 to -10.7 mg HO/L ( <. 001) with high ambient temperature, except for the Precision Flow. Increasing flow did not significantly affect AH except for the Precision Flow (from 36.4 ± 1.6 to 29.8 ± 0.2 mg HO/L at 10 and 40 L/min, respectively, [ < .001]). The lowest AH was encountered with the Optiflow set with noninvasive ventilation (NIV) mode, without compensation algorithm, and at high ambient temperature (14.2 ± 1.5 mg HO/L). In studied subjects, AH significantly affected breathing comfort, reduced from 7.0 ± 1.0 to 3.0 ± 2.0 at 40 and 20 mg HO/L, respectively, ( < .001). Comfort was similar at 30 and 40 mg HO/L.

Conclusions: When used according to manufacturer's recommendations and at normal ambient temperature, all the HFNC devices evaluated achieved satisfactory hygrometric output with respect to breathing comfort evaluated in healthy subjects (≥ 30 mg HO/L). Substantial differences exist between devices, and optimal knowledge of their working principles is required as inappropriate usage may dramatically alter efficacy and clinical tolerance.

Download full-text PDF

Source
http://dx.doi.org/10.4187/respcare.09085DOI Listing

Publication Analysis

Top Keywords

nasal cannula
12
clinical tolerance
12
high-flow nasal
8
[formula text]
8
precision flow
8
ambient temperature
8
temperature settings
8
hygrometric performances
4
performances high-flow
4
cannula devices
4

Similar Publications

Not everything is delirium at the end of life: a case report.

Ann Palliat Med

September 2025

Department of Palliative Care, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Background: Delirium is a common condition at the end of life and causes significant distress in patients and their loved ones. A precipitant factor can be found in less than half of the patients and the management interventions are limited.

Case Description: A patient in his late sixties with low English proficiency with a metastatic neuroendocrine tumor was transferred to a palliative care unit on non-invasive bilevel ventilation.

View Article and Find Full Text PDF

The current study sought to explore the impact of a novel noninvasive treatment called transcranial photobiomodulation (PBM) on resting-state functional connectivity (rsFC) of the cerebellum in individuals with a history of repetitive head acceleration events (RHAEs). RHAEs are associated with cumulative neurological compromise, including chronic alterations in rsFC; however, few treatments have been investigated to mitigate these effects. A recent study by our team demonstrated that PBM treatment led to improvements in measures of balance and motor function in adults with RHAE exposure.

View Article and Find Full Text PDF

Historical and Potential Modern Uses of Negative-Pressure Ventilation for Critically Ill Patients.

Respir Care

September 2025

Dr. Thomasian and Prof. Wunsch are affiliated with Department of Anesthesiology, Weill Cornell Medicine, New York, New York, USA.

Negative-pressure ventilation (NPV) is a form of noninvasive respiratory support in which an external subatmospheric pressure is applied to the thorax to facilitate lung expansion. Although largely supplanted by positive-pressure ventilation (PPV) in modern-day practice, NPV has garnered renewed interest as a potential noninvasive adjunct or alternative to PPV. Appropriate patient selection would be key, particularly in the ICU setting, where NPV is generally contraindicated in patients with severe upper airway obstruction, high oxygenation requirements, or absent airway reflexes.

View Article and Find Full Text PDF

Where possible, antimicrobials, such as clindamycin, should be given orally rather than intravenously when efficacy will be equivalent. A single-centre pre-/post-intervention study was conducted. There were 11 134 patients admitted to included wards during the study period.

View Article and Find Full Text PDF

Background And Purpose: The pathological role of the bile acid receptor TGR5/GPBA in Alzheimer's disease (AD) is not fully understood. We investigated the pharmacological effects and mechanisms of TGR5 in AD model mice.

Experimental Approach: TGR5 expression was assessed in AD mice using immunofluorescence and immunoblotting.

View Article and Find Full Text PDF